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Objective: To investigate the ability of a novel mouthwash comprised of 0.8% arginine, PVM/
MA copolymer, pyrophosphates, and 0.05% sodium fluoride in an alcohol-free base (Pro-
ArginTM Mouthwash Technology) to reduce dentine permeability.
Methods: Hydraulic conductance was used to assess the dentine permeability effects of the
arginine mouthwash. Aqueous solutions containing arginine and PVM/MA copolymer were
studied in the initial stage of the method development. The acid resistance was tested with a
cola drink challenge. Finally, a blinded study was carried out to determine the occlusion of
the arginine mouthwash in comparison to a negative control mouthwash.
Results: Dentine discs treated with the arginine mouthwash showed an average fluid
reduction of 42%, which was statistically, significantly better than the fluid reduction for
the negative control mouthwash. In addition, experiments using simple solutions of argi-
nine and PVM/MA copolymer, alone and in combination, demonstrated that the combina-
tion of the two was required to provide a relevant occlusion benefit. Finally, the occlusion
provided by the arginine mouthwash was maintained after exposure to an acid challenge.
Conclusion: The exclusive combination of ingredients in the arginine mouthwash has been
proven to be efficacious in decreasing dentine fluid flow as measured by hydraulic conduc-
tance. The new mouthwash works by occlusion, due to the unique combination of arginine,
PVM/MA copolymer and pyrophosphates.
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Dentine hypersensitivity is a complex and painful oral
condition that affects 4–57% adults in the world. Because of
its poorly understood aetiology, the proper diagnosis is
established after the exclusion of any other possible causes
of the pain.1–4 The most accepted explanation for dentine
hypersensitivity is based on Bra¨nnstro¨m’s hydrodynamic
theory,5,6 which considers dentine tubules to be capillary* Corresponding author at: Colgate-Palmolive Technology Center, 909 
E-mail address: sarita_mello@colpal.com (S.V. Mello).
0300-5712   # 2012 Elsevier Ltd.
http://dx.doi.org/10.1016/j.jdent.2012.11.017
Open access under CC BY-NC-ND license. tubes where the fluid behaviour obeys the laws of fluid
movement. It is postulated that various stimuli, such as cold,
heat, pressure, and sweet, cause inward or outward displace-
ment of the fluid in the dentine tubules activating the nerve
endings at the pulp/dentine interface, resulting in pain.
Dentine tubules are exposed when there is loss of enamel,
cementum and overlying periodontal tissues due to attrition/
abrasion/erosion, gingival recession or periodontal therapy.
In order to treat hypersensitivity, two major methodologies
have been identified as efficacious: (1) nerve desensitisation byRiver Road, Piscataway, NJ 08855-1343, USA.
Fig. 1 – Hydraulic conductance test schematic diagram. A
water reservoir is kept 70 cm above the Pashley’s chamber
level. The water flow is controlled by the air bubble
displacement in the glass capillary tube and recorded by
the Flodec sensor.
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fluid movement by blocking the dentine tubules (occlusion).
Dentifrices containing a potassium salt are broadly used to
desensitise the nerves, with typical efficacy observed after
four to eight weeks of continued use of the product.7–9
Occlusion agents are generally delivered through over-the-
counter dentifrices, although more recently this approach has
been applied more widely through the use of professional
desensitising applications or in-office resin applications.
The use of hydraulic conductance to assess dentine fluid
flow has been established by Pashley and co-workers10–14 and is
a valuable in vitro method to evaluate products that work via
dentine occlusion. It has been largely used to screen dentifrices
and other highly viscous products that deposit solid particles on
dentine tubules or form thick adhesive layers on the dentine
surface.14 Such products block dentine fluid flow, resulting in
reduction of fluid flow, ultimately associated with decrease of
dentine hypersensitivity.In 2009, a new breakthrough technol-
ogy was introduced, based upon arginine and calcium carbon-
ate, as an in-office professional treatment and as a daily use
fluoride-containing dentifrice. The efficacy of the arginine-
based technology has been proven in numerous clinical studies
as well as in laboratory studies.15–22
Studies describing the clinical efficacy of mouthwash as a
delivery system to address dentine hypersensitivity are
inconclusive.23–26 For instance, Pereira et al.23 compared a
3% potassium nitrate/0.2% sodium fluoride mouthrinse to a
0.2% sodium fluoride control mouthrinse in a six-week double
blind study. They found that both products decreased the
intensity of hypersensitivity, with no difference between
products after two weeks. Only after six weeks was there a
statistically significant difference in sensitivity as measured
by cold air blast between the groups favouring the potassium
nitrate containing group. There was no difference after six
weeks using tactile measurements. On the other hand Gillam
et al.24 did detect a difference at both two and six weeks
between a 3% potassium nitrate and sodium fluoride
mouthwash and a sodium fluoride mouthwash.
The objective of the present study was to investigate the
in vitro performance of a novel mouthwash technology (Pro-
ArginTM Mouthwash Technology) that provides dentine
occlusion27 with a consequent reduction of hydraulic conduc-
tance. The new technology is based on the delivery of an
adhesive complex formed by arginine/copolymer/pyropho-
sphates at the microscopic scale. An adaptation of Pashley’s
method described in Kleinberg’s work28 has been developed to
enable the in vitro study of fluid samples such as mouthwash
via hydraulic conductance. The use of Pashley cell instead of
dentine segments has proven to be successful for screening
mouthwash formulations with high reproducibility results.
2. Materials and methods
2.1. Test materials
The test mouthwash (‘‘Arginine’’) consisted of 0.8% arginine,
polyvinylmethyl ether/maleic acid (PVM/MA) copolymer,
pyrophosphates and 0.05% sodium fluoride (Colgate-Palmol-
ive Company, New York, NY). The control mouthwash(negative control) was a non-commercial, fluoride free
prototype that had the same ingredients as the arginine
mouthwash without the occlusion system. In addition,
aqueous solutions of arginine and PVM/MA copolymer, alone
and in combination, were evaluated along with early proto-
types of the arginine mouthwash.
2.2. Dentine disc preparation10
Dentine discs were prepared from extracted human molars
(Dental Product Testing, IN). Specimens, 0.8 mm thick, were
obtained by using a slow-speed saw turning a diamond grit
blade (Buehler Isomet). Each dentine disc was dipped into 6%
(w/v) citric acid for 1 min to remove the smear layer created by
the blade. The dentine discs were mounted in a polycarbonate
split-chamber device – Pashley cell, also called Pashley split
chamber (Kenward Company, GA) – with spacers containing
silicon ‘‘O’’ rings to limit the test surface area to 0.28 cm2. The
upper half with the exposed dentine surface was open and the
lower half was closed except for 18 gauge stainless steel tubing
that was used for inlet and outlet conduits. The orientation of
the dentine discs was occlusal side up, pulpal side towards the
lower chamber. This orientation was always confirmed by
noting the magnifying properties of the occlusal–pulpal
orientation and the reducing properties of the pulpal–occlusal
orientation.
2.3. Measurements of the hydraulic conductance of
dentine
Hydraulic conductance measurements were carried out using
a flow sensor – Flodec (De Marco Engineering, Switzerland) –
under simulated pulpal pressure of 70 cm created by a syringe
connected to the capillary tube via polystyrene tubing. The
displacement of a meniscus created by an air bubble in the
Table 1 – Percentage fluid flow reduction and baseline flow.
Baseline flow (mL min1 cm2) 6 6 9 9 9 11 18 18 22 26
% flow reduction @ 30 min 42 71 44 47 70 61 62 52 49 45
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The flow data was converted to permeability (mL min1) via
dedicated Flodec software. A schematic diagram is shown in
Fig. 1. After filling the chamber with water and, the Pashley cell
was connected to Flodec with the polystyrene tubing. Leakage
was circumvented by wrapping the connections with TeflonTM
tape. Dentine permeability was measured before and after
application of the study solutions/products. The in vitro
‘‘treatment’’ has been adapted from Kleinberg’s work,28 where
water dispersions of arginine bicarbonate and calcium
bicarbonate have been tested for the ability to reduce dentine
fluid flow. In our study, a ‘‘treatment’’ consisted of the
following steps:
1. Application of 400 mL sample on dentine disc for 10 min @
nil pressure.
2. Rinsing w/400 mL phosphate buffer saline (PBS)
3. Application of 400 mL PBS for 10 min under 70 cm water
pressure (simulated pulpal pressure)
4. Repetition of steps 1&2
5. Application of 400 mL PBS for 30–90 min under simulated
pulpal pressure.
The percentage flow reduction was based on the calcula-
tion of a flow reduction after a given time under simulated
pulpal pressure in comparison to its own baseline: ((Baseline
flow – Treatment flow)/Baseline flow)*100. Due to the natural
variability of the dentine specimens, a minimum of 6 samples
were tested each time a study was conducted to test the
occlusion efficacy of a mouthwash.
2.4. Arginine mouthwash vs. negative control
mouthwash
A two-cell, randomised in vitro study was performed on
human dentine discs, assigned accordingly to 16 independent
runs. The two mouthwash formulas described in Section 2
were tested 8 times, i.e., eight distinct dentine discs wereFig. 2 – Dentine fluid reduction of mouthwash prototype
containing arginine and PVM/MA copolymer.assigned to each cell. The person performing the experiments
as well as the people analysing the results were blinded to the
identity of the test materials.
A one-way analysis of variance model was performed to
determine if a statistically significant difference ( p < 0.05)
existed among the two products.
3. Results
Fig. 2 shows hydraulic conductance results in the form of
percentage reduction of discs treated with solutions of
arginine, PVM/MA copolymer, and the combination of the
two. The modest reductions provided by arginine alone and
the PVM/MA copolymer alone indicate a minimal occlusive
effect. The combination of the two provided a reduction of 39%
indicating occlusion. These results were measured 90 min
after treatment, which was sufficient to allow the formation of
an ionic complex between arginine and the PVM/MA copoly-
mer and could potentiate the formation of an adhesive
complex at the microscopic scale under the conditions of
the study.
The occlusion efficacy was further tested using a mouth-
wash prototype containing arginine and PVM/MA in combi-
nation with typical mouthwash ingredients, including
pyrophosphates. A 90 min experiment is presented in Fig. 3.
The percentage flow reduction at 90 min is comparable to that
of the combination of the arginine and PVM/MA copolymer,
indicating that the presence of typical mouthwash ingredients
have not compromised occlusion. Based upon the learning of
these initial studies, all subsequent studies were measured at
30 min, because the major change in flow occurred between
15 min and 45 min.
Another important investigation was to determine the
acceptable baseline range to measure the effect of mouthwash
on simulated dentine fluid flow. The same prototype mouth-
wash as previously tested was tested 10 times at 30 min using
baselines within the range of 6–26 mL min1 cm2, as pre-
sented in Table 1. As the results indicate, no direct correlation
between percentage reduction and baseline was observed.Fig. 3 – Dentine fluid flow reduction of aqueous solutions
90 min after treatment.
Fig. 4 – Dentine fluid reduction of arginine mouthwash
containing arginine, PVM/MA copolymer and
pyrophosphates.
Fig. 5 – Dentine fluid reduction of arginine mouthwash as
compared to negative control mouthwash.
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acceptable for mouthwash measurements.
The acid-resistance ability of the arginine mouthwash was
evaluated using a cola drink challenge.18 Results comparing
before and after cola challenge are shown in Fig. 4. There is no
statistical difference in the occlusion efficacy after cola
challenge, which suggests an overall acid-resistance of the
occlusion system formed by the arginine mouthwash.
Finally, the arginine mouthwash was compared to a
negative control mouthwash in a blinded study. Eight different
dentine discs were assigned to each sample. Fig. 5 shows the
average percentage of flow reduction. There was an average of
42% reduction in fluid flow for the arginine mouthwash;
whereas there was only a 9% reduction in fluid flow for the
negative control mouthwash at the end of each treatment.
This difference was statistically significant ( p < 0.0005).
4. Discussion
The development of a clinically efficacious mouthwash to
alleviate dentine hypersensitivity has been a challenge
pursued by researchers for many decades without unequivo-
cal outcome. One of the objectives of the work presented
herein was to develop a reliable in vitro test to study the
performance of anti-hypersensitivity mouthwash formula-
tions which potentially occlude dentine tubules. The adapta-
tion of Kleinberg’s study based on Pashley cell’s method was
key to achieve reliable in vitro results which ultimately were
confirmed by clinical studies reported by Hu et al.29 and Boneta
et al.30 Different from other commercially available
mouthwashes recommended for the treatment of hypersen-
sitivity, the arginine mouthwash does not contain potassium
nitrate or potassium citrate, common hypersensitivity ingre-
dients. Its mode of action is based on the decrease of dentine
permeability, which is accomplished by occlusion.27 The
combination of arginine, PVM/MA copolymer and pyrophos-
phate salts formulated in the appropriate pH and ionic
strength environment is proposed to form an adhesive
complex that builds up upon repeated applications, resulting
in the reduction of hydraulic conductance, ultimately linked tothe mitigation of dentine hypersensitivity. The hydraulic
conductance results for simple solutions (Fig. 2) of arginine,
PVM/MA and their combination indicate the benefit in
occlusion efficacy of combining these two ingredients. One
can assume that after the polymer has been neutralised by the
negative sites of the arginine molecule, a net negative charge
will result in the system allowing it to adhere on to the dentine
surface. Moreover, occlusion is not compromised when the
complex is incorporated in a full mouthwash formulation
(Fig. 3). The comparison between the arginine mouthwash and
the negative control mouthwash corroborates the proposed
mechanism of dentine occlusion (Fig. 5). Further supporting
data for this mechanism is presented elsewhere in this Special
Issue.27 The acid-resistance of the arginine mouthwash was
assessed by the application of cola drink presented in Fig. 4.
This method has been used to mimic the challenge that occurs
in the oral environment after the exposure to acidic foods.18 In
the case of toothpaste treatment, where the occlusion is
primarily based on the deposition of solid particles, the cola
challenge helps to discriminate weak and soluble deposition
system from stable and resistant occlusion. Techniques such
as Scanning Electron Microscopy (SEM) and Confocal Laser
Scanning Microscopy (CLSM) are appropriated to investigate
such systems. However, when one needs to study a low
viscosity system such as a mouthwash, the Pashley cell
provides the best in vitro technique to mimic the oral
environment. In such setting, the hydraulic conductance is
measured under simulated pulpal pressure in presence of PBS.
A non-statistically significant change in the flow for the
arginine mouthwash after exposure to an acid challenges
indicates the resistance of the adhesive complex.
The measure of dentine permeability is a quantitative
in vitro method used to study occlusion of toothpastes and
other products containing solid particles that plug dentine
tubules. In the present paper, we have widened the approach
to measure the dentine occlusion of mouthwashes, which
involved many experimental adaptations. In particular, we
determined the optimal range of baseline permeability
suitable for mouthwash evaluation (Table 1), and we fixed
the time for data collection (Fig. 3), minimising the variability
intrinsic of in vitro studies using human dentine specimens.
The development of a reliable in vitro method is crucial for
designing new products, because it allows the screening and
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explain the mode of action. The occlusion of dentine tubules
with the arginine mouthwash is the basis of the relief of
dentine hypersensitivity as demonstrated in two clinical
studies.29,30
5. Conclusion
A new mouthwash containing arginine, PVM/MA copolymer,
pyrophosphates and sodium fluoride has been shown to
reduce hydraulic conductance and therefore may be appro-
priate to the treatment of dentine hypersensitivity. Such a
composition suggests the formation of an arginine/copolymer
complex that occlude dentine tubules, which may explain the
observed reduction in dentine fluid permeability, in vitro.
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